Developmental toxicity of nondepolarizing muscle relaxants in cultured rat embryos.
Evidence of developmental toxicity of clinically used nondepolarizing muscle relaxants was sought in rat embryos grown in culture. Embryos were explanted at 8 AM on day 9 of gestation (presomite stage, plug day = day 0), and were cultured in rotating bottles with medium containing various concentrations of d-tubocurarine, pancuronium, atracurium, and vecuronium. At 10 AM on day 11 of gestation (forelimb bud stage), culture was terminated and embryos were examined for general morphology. Treatment with tested agents resulted in dose-dependent developmental toxicity; namely, growth retardation seen as decreased crown-rump length, decreased number of somite pairs, and morphologic abnormalities. However, the concentrations that caused toxicity were at least 30-fold greater than serum concentrations clinically achieved in the mother. We conclude that these muscle relaxants have a low potential for causing developmental toxicity during organogenesis.
Department of Anesthesia, Stanford University School of Medicine, California.
M
M
Fujinaga
J M
JM
Baden
R I
RI
Mazze
D000818:Animals; D001279:Atracurium / Q000633:toxicity; D004622:Embryo, Mammalian / Q000187:drug effects*; D005314:Embryonic and Fetal Development; D005260:Female; D066298:In Vitro Techniques; D008297:Male; D003473:Neuromuscular Nondepolarizing Agents / Q000633:toxicity*; D010197:Pancuronium / Q000633:toxicity; D051381:Rats; D011919:Rats, Inbred Strains; D014403:Tubocurarine / Q000633:toxicity; D014673:Vecuronium Bromide / Q000633:toxicity
D003473:Neuromuscular Nondepolarizing Agents; D001279:Atracurium; D014673:Vecuronium Bromide; D010197:Pancuronium; D014403:Tubocurarine